The neurobiology of attention.
Conditions
Interventions
Pilot is a drug-free pilot aimed to verify results (ERPs / behavioral data) of previous studies, 12 participants will be included.
The final study will contrast clonidine (0.1mg) and placebo. Like th
Sponsors
H.N.A. Logemann, MSc.
Utrecht University
Dept. Experimental Psychology/Pharmaceutical Sciences.
Heidelberglaan 2
1584 CS Utrecht
Room 17.10
tel: +31 (0)30 2533386 / +31 (0)622233928
fax: +31 (0)30 2534511
e-mail: H.N.A.Logemann@uu.nl
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants must be between 18 – 40 years old; 2. Passing the medical screening (in which cardiovascular functioning and blood pressure is evaluated) is a prerequisite.
Exclusion criteria
Exclusion criteria: 1. Use of any medication; 2. Low blood pressure, systolic bp under 100 mmHg, diastolic under 70 mmHg.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Behavioural measures; 2. In the Visual Spatial Cuing (VSC) paradigm: the validity effect in ms (RT valid cued target - RT invalid cued target). A larger validity effect reflects either more bias, or less disengagement; 3. In the stop task paradigm: the stop signal reaction time (SSRT); SSRT reflects inhibition and related disengagement; 4. Neurophysiological EEG (ERP) endparameters in the VSC: A. Parietal cue ERP components (ADAN + LDAP), related to bias; B. P1 valid cued target ERP, related to bias; C. LPD invalidly cued target ERP, related to disengagement. 5. Neurophysiological (ERP) endparameters in the stop task: A. N2 stop signal ERP, related to disengagement; B. LPD stop signal ERP, related to disengagement. | — |
Contacts
Public ContactH.N.A. Logemann
Outcome results
None listed